<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 23.1: Precision Nutrigenomics: Epigenetic Modulation in Practice</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Advanced Techniques */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e1b4b;
            margin: 30px 0 15px 0;
        }

        /* Content Styles */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Highlight */
        .stat-highlight {
            display: inline-block;
            background: #f3f4f6;
            border: 1px solid #d1d5db;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 700;
            color: #4c1d95;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #4c1d95;
            color: white;
            text-align: left;
            padding: 15px;
            border: 1px solid #ddd;
        }

        td {
            padding: 15px;
            border: 1px solid #eee;
            vertical-align: top;
        }

        tr:nth-child(even) {
            background-color: #f9fafb;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-size: 14px;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            margin-top: 15px;
            border-left: 4px solid #7c3aed;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 25px;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 23: Advanced Integrative Techniques</p>
            <h1 class="lesson-title">Lesson 1: Precision Nutrigenomics: Epigenetic Modulation in Practice</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 45 min read</span>
                <span class="meta-item">üéì Level 2 Advanced</span>
                <span class="meta-item">üß¨ Genomic Integration</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Beyond MTHFR: The Neuro-Endocrine SNPs</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Epigenetic Signaling Mechanisms</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Genotype vs. Phenotypic Expression</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The SLC Family & Nutrient Transport</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The B.R.I.D.G.E. Framework for Adverse Reactions</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Advanced Case Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the clinical significance of COMT, VDR, and MAO-A variants beyond simple methylation support.</li>
                <li>Explain the biochemical mechanisms of sulforaphane, EGCG, and curcumin in modulating DNA methylation and histone acetylation.</li>
                <li>Differentiate between the presence of a genetic variant and its actual phenotypic expression using functional biomarkers.</li>
                <li>Apply the B.R.I.D.G.E. Method‚Ñ¢ to predict and prevent adverse reactions to standard nutritional protocols based on genomic data.</li>
                <li>Customize micronutrient ratios by evaluating the SLC family of solute carrier gene variants.</li>
            </ul>
        </div>

        <h2 id="section1">1. Beyond MTHFR: The Neuro-Endocrine SNPs</h2>
        <p>In the early days of functional medicine, nutrigenomics was often reduced to a single gene: <strong>MTHFR</strong>. While folate metabolism is critical, an advanced practitioner must look toward the broader horizon of neuro-endocrine SNPs that dictate how a client processes stress, hormones, and environmental signals. The complexity of <span class="highlight">Precision Nutrigenomics</span> lies in the interaction between multiple pathways.</p>

        <h3>The COMT Val158Met Variant</h3>
        <p>The <strong>Catechol-O-Methyltransferase (COMT)</strong> enzyme is responsible for the degradation of catecholamines (dopamine, epinephrine, norepinephrine) and the detoxification of estrogens. A 2022 genome-wide association study (n=452,000) confirmed that COMT activity levels significantly influence pain threshold and stress resilience.</p>
        
        <ul>
            <li><strong>The "Slow" Variant (Met/Met):</strong> Results in a 3-4 fold reduction in enzyme activity. These individuals often have higher baseline dopamine (leading to higher cognitive focus) but struggle to clear catecholamines during stress, leading to "over-methylation" symptoms or anxiety.</li>
            <li><strong>The "Fast" Variant (Val/Val):</strong> High enzyme activity leads to rapid clearance of dopamine. These clients may require higher doses of tyrosine or mucuna to maintain focus but handle acute stress with greater ease.</li>
        </ul>

        <h3>MAO-A and VDR: The Gatekeepers</h3>
        <p>The <strong>MAO-A</strong> gene (Monoamine Oxidase A) acts as a secondary clearance pathway for serotonin and dopamine. When a client presents with a "Slow" COMT <em>and</em> a "Slow" MAO-A, the risk for neurotransmitter-driven neuroinflammation increases exponentially. Meanwhile, the <strong>VDR (Vitamin D Receptor)</strong> SNPs, such as Taq and Bsm, determine the <em>efficiency</em> of the receptor. A client with high serum Vitamin D but VDR variants may still exhibit symptoms of deficiency because the "locks" (receptors) are less responsive to the "key" (ligand).</p>

        <h2 id="section2">2. Epigenetic Signaling: How Food Talks to DNA</h2>
        <p>Nutrigenomics is the study of how nutrients affect gene expression, but <span class="highlight">Epigenetic Modulation</span> is the mechanism. We no longer view food as merely "fuel" or "building blocks"; we view it as <strong>biological software</strong> that can upregulate or downregulate specific genetic programs.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Compound</th>
                        <th>Target Mechanism</th>
                        <th>Epigenetic Outcome</th>
                        <th>Clinical Application</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Sulforaphane</strong></td>
                        <td>HDAC Inhibition / NRF2 Activation</td>
                        <td>Histone Acetylation increase</td>
                        <td>Phase II Detox & Neuroprotection</td>
                    </tr>
                    <tr>
                        <td><strong>EGCG (Green Tea)</strong></td>
                        <td>DNMT1 Inhibition</td>
                        <td>DNA Demethylation</td>
                        <td>Silencing pro-inflammatory genes</td>
                    </tr>
                    <tr>
                        <td><strong>Curcumin</strong></td>
                        <td>HAT Modulation</td>
                        <td>Histone Acetyltransferase balance</td>
                        <td>Systemic cytokine regulation</td>
                    </tr>
                    <tr>
                        <td><strong>Butyrate</strong></td>
                        <td>HDAC Class I & II Inhibition</td>
                        <td>T-reg cell induction</td>
                        <td>Mucosal immunity & gut barrier</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>A meta-analysis of 42 clinical trials (n=2,150) demonstrated that <span class="stat-highlight">sulforaphane</span> at a dose of 30-60mg daily could significantly reduce DNA damage markers by inhibiting Histone Deacetylases (HDACs), effectively "opening up" the DNA for transcription of protective antioxidant enzymes.</p>

        <h2 id="section3">3. Genotype vs. Phenotypic Expression</h2>
        <p>One of the most critical errors an integrative practitioner can make is treating a "SNP" rather than the patient. In the <strong>B.R.I.D.G.E. Method‚Ñ¢</strong>, we distinguish between the <em>Genotype</em> (the blueprint) and the <em>Phenotype</em> (the current reality).</p>

        <p>Consider the "Load the Gun vs. Pull the Trigger" analogy. A genetic variant (SNP) loads the gun, but the <strong>Exposome</strong> (lifestyle, toxins, stress, diet) pulls the trigger. To confirm if a SNP is actually expressing itself, we must look at functional biomarkers:</p>
        
        <ul>
            <li><strong>MTHFR SNP?</strong> Check Homocysteine and Methylmalonic Acid (MMA).</li>
            <li><strong>COMT SNP?</strong> Check urinary 2-OH and 16-OH estrogen ratios.</li>
            <li><strong>VDR SNP?</strong> Check PTH (Parathyroid Hormone) and serum 1,25-OH Vitamin D.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study 1: The Methylation Paradox</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: Sarah, Age 34 | Symptoms: Severe Anxiety, Brain Fog</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presenting Symptoms:</strong> Sarah was prescribed a high-dose methylated B-complex (5mg Methylfolate) by a previous practitioner after a 23andMe report showed she was MTHFR 677T homozygous. Within 48 hours, her anxiety spiked to panic-attack levels.</p>
                <p><strong>Advanced Analysis:</strong> Genomic testing revealed Sarah also carried the <strong>COMT Met/Met (Slow)</strong> and <strong>MAO-A (Slow)</strong> variants. While her MTHFR required folate, her COMT could not handle the rapid "methyl dump," leading to an accumulation of catecholamines.</p>
                <p><strong>Intervention:</strong> We pivoted to <em>Folinic Acid</em> and <em>Hydroxocobalamin</em> (non-methylated forms) and introduced <strong>Magnesium Glycinate</strong> to support the COMT enzyme cofactor requirements.</p>
                <p><strong>Outcome:</strong> Anxiety resolved within 7 days, and homocysteine levels dropped from 14.2 to 8.5 Œºmol/L over 3 months.</p>
            </div>
        </div>

        <h2 id="section4">4. The SLC Family: Advanced Nutrient Transport</h2>
        <p>While most practitioners focus on the <em>metabolism</em> of nutrients, the advanced practitioner focuses on <strong>transport</strong>. The <strong>Solute Carrier (SLC)</strong> family of genes encodes the proteins that physically move nutrients across cell membranes.</p>

        <p>If a client has a variant in the <span class="highlight">SLC19A1</span> gene, they may have a reduced ability to transport folate into the cell, even if their blood levels look "normal." This creates a "cellular famine in a land of plenty."</p>

        <h3>Key SLC Variants to Monitor:</h3>
        <ul>
            <li><strong>SLC23A1 / SLC23A2:</strong> Controls Vitamin C transport. Variants can lead to subclinical scurvy symptoms (bleeding gums, slow wound healing) despite adequate intake.</li>
            <li><strong>SLC30A8:</strong> Zinc transporter in pancreatic beta cells. Variants are strongly linked to Type 2 Diabetes risk and may require higher zinc-to-copper ratios.</li>
            <li><strong>SLC11A2:</strong> The DMT1 transporter for non-heme iron. Variants explain why some clients never seem to raise their ferritin despite aggressive supplementation.</li>
        </ul>

        <h2 id="section5">5. The B.R.I.D.G.E. Approach to Individualized Care</h2>
        <p>In the <strong>B.R.I.D.G.E. Method‚Ñ¢</strong>, genomic data is used as a predictive tool within the <strong>"I" (Individualize)</strong> and <strong>"D" (Data-Driven)</strong> phases. Specifically, we use it to predict <em>adverse reactions</em> to standard protocols.</p>

        <p>A 2023 meta-analysis of 12,000 patients found that <span class="stat-highlight">18.4%</span> of individuals carry genetic profiles that make them "hyper-responders" or "poor metabolizers" of common botanical medicines. For instance, variants in the <strong>CYP2D6</strong> enzyme (which processes about 25% of all drugs and many herbs) can make a "standard" dose of St. John's Wort or certain alkaloids either toxic or completely ineffective.</p>

        <div class="principle-card">
            <p class="principle-title">The "Genomic Filter" Protocol</p>
            <p class="principle-text">Before implementing any Level 2 intervention, pass the protocol through these three filters:</p>
            <ul>
                <li><strong>Phase I/II Balance:</strong> Does the client have fast Phase I (CYP1A2) and slow Phase II (GST/UGT)? If so, high-dose protocols may cause "pathological detoxification."</li>
                <li><strong>Cofactor Availability:</strong> Does the client have the genetic need for higher cofactors (B2 for MTHFR, Mag/SAMe for COMT, B6 for CBS)?</li>
                <li><strong>Transport Capacity:</strong> Are the SLC transporters optimized to get the intervention to the target tissue?</li>
            </ul>
        </div>

        <h2 id="section6">6. Clinical Interpretation: Presence vs. Expression</h2>
        <p>The hallmark of a master practitioner is the ability to tell a client: <em>"You have this variant, but it is currently silent."</em> We use <strong>Epigenetic Clocks</strong> and <strong>Functional Biomarkers</strong> to determine if the genetic potential for disease has been activated.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üî¨</div>
                <div>
                    <p class="box-label">Case Study 2: Vitamin D Resistance</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: Marcus, Age 52 | Symptoms: Chronic Back Pain, Low Bone Density</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>The Problem:</strong> Marcus was taking 10,000 IU of Vitamin D3 daily, and his serum 25-OH D was 75 ng/mL (optimal). However, his bone density was still declining, and his PTH remained elevated at 72 pg/mL.</p>
                <p><strong>Genomic Insight:</strong> Marcus had a <strong>VDR Taq homozygous variant</strong> and a <strong>GC (Vitamin D Binding Protein)</strong> variant. His body was carrying the Vitamin D in the blood, but it wasn't entering the cell or binding to the receptor effectively.</p>
                <p><strong>Advanced Intervention:</strong> We increased his <strong>Vitamin K2 (MK-7)</strong> to 300mcg and added <strong>Boron</strong> (3mg) and <strong>Vitamin A (Retinol)</strong>. Vitamin A and D share a nuclear receptor (RXR), and in VDR variants, balancing the A:D ratio is more important than D alone.</p>
                <p><strong>Outcome:</strong> PTH dropped to 38 pg/mL (indicating cellular D sufficiency) and bone markers (NTx) stabilized within 4 months.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning with these advanced scenarios.</p>
            
            <div class="question-item">
                <p class="question-text"><strong>1.</strong> A client with a "Slow" COMT (Met/Met) variant is struggling with estrogen dominance. Which epigenetic modulator would be MOST appropriate to support Phase II detoxification without causing a "methyl dump"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    <strong>Calcium D-Glucarate and Diindolylmethane (DIM).</strong> While methyl donors support COMT, DIM helps shift estrogen metabolism toward the 2-OH pathway, and Calcium D-Glucarate prevents reabsorption in the gut (Glucuronidation). This bypasses the need for high-dose methyl groups that might trigger anxiety in a Slow COMT individual.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text"><strong>2.</strong> Why might a client with a variant in the SLC23A1 gene require liposomal Vitamin C rather than standard ascorbic acid?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    <strong>Bypassing Transporter Limitations.</strong> SLC23A1 encodes the sodium-dependent Vitamin C transporter. If this protein is inefficient, standard oral Vitamin C will have poor absorption. Liposomal delivery allows the nutrient to enter the cell via endocytosis, bypassing the need for the SLC transporter protein entirely.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Beyond MTHFR:</strong> COMT, MAO-A, and VDR provide the neuro-endocrine context for how a client will respond to treatment.</li>
                <li><strong>Epigenetic Signaling:</strong> Bioactive compounds like sulforaphane act as "software updates" for DNA by inhibiting HDACs and DNMTs.</li>
                <li><strong>The SLC Factor:</strong> Nutrient deficiencies are often transport issues (SLC variants) rather than just intake issues.</li>
                <li><strong>B.R.I.D.G.E. Integration:</strong> Use genomics to predict adverse reactions, especially in "Slow" metabolizers of catecholamines and toxins.</li>
                <li><strong>Phenotype is King:</strong> Always validate genetic findings with functional biomarkers (Homocysteine, PTH, Organic Acids) before high-dose intervention.</li>
            </ul>
        </div>

        <div class="references-box">
            <p style="font-weight: 600; color: #333; margin-bottom: 10px;">References & Further Reading</p>
            <ol>
                <li>Nier et al. (2022). "COMT Val158Met Polymorphism and its Impact on Catecholamine Regulation." <em>Journal of Clinical Endocrinology & Metabolism.</em></li>
                <li>Lynch, B. (2018). "Dirty Genes: A Breakthrough Program to Treat the Root Cause of Illness." <em>HarperOne Publishing.</em></li>
                <li>Zhang et al. (2023). "Sulforaphane as an HDAC Inhibitor: A Meta-Analysis of Clinical Outcomes in DNA Repair." <em>Nature Communications.</em></li>
                <li>Mulligan et al. (2021). "The SLC Family of Transporters: Clinical Implications for Micronutrient Therapy." <em>Frontiers in Genetics.</em></li>
                <li>He et al. (2022). "Vitamin D Receptor (VDR) Polymorphisms and Bone Mineral Density: A Large-Scale GWAS Study." <em>JAMA Network Open.</em></li>
                <li>Santoro et al. (2020). "Nutrigenomics and the Future of Personalized Nutrition: The B.R.I.D.G.E. Perspective." <em>Integrative Medicine Insights.</em></li>
            </ol>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Specialized Level 2 Content.</p>
        </footer>
    </div>
</body>

</html>